NASDAQ:BBIO

Bridgebio Pharma Stock Insider Trading

etoro logo Buy BBIO
*Your capital is at risk
$65.48
+1.60 (+2.50%)
At Close: Jun 03, 2026

Bridgebio Pharma Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -80.57. In total, the insiders bought 728.07K and sold 624.83K BBIO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-80.57
Buy 728.07K shares
Sell 624.83K shares
28% Buy Activity
Moderate Negative Correlation
Buy Signal Low Confidence
Mar 18, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -80.57.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Mar 13, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 10 310
Value: $713.4K
Mar 13, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 9 690
Value: $662.4K
Mar 13, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 9 759
Value: $675.6K
Mar 12, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 5 815
Value: $402.9K
Mar 12, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 300
Value: $21.0K
Mar 12, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 13 885
Value: $950.7K
Mar 12, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 300
Value: $21.0K
Mar 12, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 5 363
Value: $371.8K
Mar 12, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 14 337
Value: $981.8K
Mar 10, 2026
Buy
Common Stock
M-Exempt
Valantine Hannah
Director
Director 8 671
Value: $237.2K
Mar 10, 2026
Sell
Common Stock
S-Sale
Valantine Hannah
Director
Director 8 671
Value: $624.3K
Mar 10, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Valantine Hannah
Director
Director 8 671
Value: $237.2K
Mar 04, 2026
Buy
Common Stock
M-Exempt
Ellis Andrea
Director
Director 64 921
Value: $548.6K
Mar 04, 2026
Buy
Stock Option (right to buy)
M-Exempt
Ellis Andrea
Director
Director 64 921
Value: $548.6K
Mar 04, 2026
Sell
Common Stock
S-Sale
Ellis Andrea
Director
Director 64 921
Value: $4.21M
Feb 27, 2026
Buy
Common Stock
M-Exempt
Valantine Hannah
Director
Director 25 484
Value: $1.23M
Feb 27, 2026
Sell
Common Stock
S-Sale
Valantine Hannah
Director
Director 14 584
Value: $978.3K
Feb 27, 2026
Sell
Common Stock
S-Sale
Valantine Hannah
Director
Director 10 900
Value: $739.5K
Feb 27, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Valantine Hannah
Director
Director 25 484
Value: $1.23M
Feb 26, 2026
Sell
Common Stock
S-Sale
Apuli Maricel
Chief Accounting Officer
Officer 2 000
Value: $132.0K
Feb 19, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 602
Value: $43.8K
Feb 19, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 8 528
Value: $614.7K
Feb 19, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 18 923
Value: $1.34M
Feb 17, 2026
Sell
Common Stock
S-Sale
Scott Randal W.
Director
Director 4 793
Value: $362.2K
Feb 17, 2026
Sell
Common Stock
S-Sale
Scott Randal W.
Director
Director 3 307
Value: $251.1K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT BRIDGEBIO PHARMA INC.
Bridgebio Pharma
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabilizer of transthyretin, or TTR that is in Phase 3 clinical trial for the treatment of TTR amyloidosis-car...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE